BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11218337)

  • 1. BCG in immunization programmes.
    Wkly Epidemiol Rec; 2001 Feb; 76(5):33-9. PubMed ID: 11218337
    [No Abstract]   [Full Text] [Related]  

  • 2. [THE CURRENT ASPECTS OF DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS OF COMPLICATIONS AFTER BCG VACCINATION].
    Tuberk Biolezni Legkih; 2010; (6):25-8. PubMed ID: 27534052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCG vaccination of young adults at risk of tuberculosis: a meaningful precaution in low-prevalence settings?
    Larsson LO; Fjällbrant H; Widström O; Ridell M
    Int J Tuberc Lung Dis; 2011 May; 15(5):709. PubMed ID: 21756528
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccine protocols to optimise the protective efficacy of BCG.
    Griffin JF; Mackintosh CG; Slobbe L; Thomson AJ; Buchan GS
    Tuber Lung Dis; 1999; 79(3):135-43. PubMed ID: 10656112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
    MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination against tuberculosis].
    Buzy P
    Rev Infirm; 2006 Feb; (118):24-5. PubMed ID: 16562548
    [No Abstract]   [Full Text] [Related]  

  • 7. At a time of global BCG shortage, attempts at optimizing BCG dose and schedule is no longer the answer.
    Morales A; Siemens DR; Koti M
    Urol Oncol; 2021 Feb; 39(2):137-138. PubMed ID: 33218921
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnostic methods of postvaccinal complications after administration of BCG vaccine].
    Zwolska Z; Augustynowicz-Kopeć E; Zabost A; Ziołkowski J; Buchwald J; Płończak M; Walas W; Ziebiński M
    Przegl Epidemiol; 2004; 58 Suppl 1():123-8. PubMed ID: 15807170
    [No Abstract]   [Full Text] [Related]  

  • 9. The nonspecific effects of vaccines and the expanded program on immunization.
    Shann F
    J Infect Dis; 2011 Jul; 204(2):182-4. PubMed ID: 21673027
    [No Abstract]   [Full Text] [Related]  

  • 10. BCG vaccines: WHO position paper – February 2018.
    Wkly Epidemiol Rec; 2018 Feb; 93(8):73-96. PubMed ID: 29474026
    [No Abstract]   [Full Text] [Related]  

  • 11. [Safety of BCG vaccinations--adverse effects following immunization. Part II. Causes of complications. Clinical management].
    Szczuka I
    Przegl Epidemiol; 2002; 56(1):15-28. PubMed ID: 12150058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence behind the WHO guidelines: hospital care for children: what is the evidence that BCG vaccination should not be used in HIV-infected children?
    Bannister C; Bennett L; Carville A; Azzopardi P
    J Trop Pediatr; 2009 Apr; 55(2):78-82. PubMed ID: 19276146
    [No Abstract]   [Full Text] [Related]  

  • 13. [Safety BCG vaccinations--adverse effects following immunization. Part I. Types, occurrence and registrations].
    Szczuka I
    Przegl Epidemiol; 2002; 56(1):1-13. PubMed ID: 12150052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bladder tumour treatment: the real BCG definitive contra-indications].
    Neuzillet Y; Lebret T
    Prog Urol; 2010 Mar; 20 Suppl 1():S41-5. PubMed ID: 20493443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of BCG vaccination policy in Europe: 1994-96.
    Trnka L; Dankova D; Zitova J; Cimprichova L; Migliori GB; Clancy L; Zellweger JP
    Bull World Health Organ; 1998; 76(1):85-91. PubMed ID: 9615500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [BCG vaccination. Immunological aspects].
    Salud Publica Mex; 1979; 21(3):321-8. PubMed ID: 550311
    [No Abstract]   [Full Text] [Related]  

  • 17. BCG installations for bladder cancer and latent tuberculosis infection.
    Hanson K
    Urol Nurs; 2002 Apr; 22(2):132-4. PubMed ID: 11993243
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety of BCG Vaccination in Pediatric Liver Transplant Recipients.
    Kinoshita N; Shoji K; Funaki T; Fukuda A; Sakamoto S; Kasahara M; Miyairi I
    Transplantation; 2018 Apr; 102(4):e125. PubMed ID: 29346255
    [No Abstract]   [Full Text] [Related]  

  • 19. Selecting the right indicators to ensure optimised implementation of BCG vaccination policy.
    Thysen SM; Fisker AB;
    Vaccine; 2018 Jun; 36(24):3406-3407. PubMed ID: 29748032
    [No Abstract]   [Full Text] [Related]  

  • 20. Efforts of identifying the place of tb infection and bcg vaccination in the hygiene hypothesis of allergy.
    Omiadze K; Telia A; Khechinashvili G
    Georgian Med News; 2006 Jul; (136):61-5. PubMed ID: 16905848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.